Transcript
Page 1: Practice Points From RA Registries and Pragmatic Trials

Practice Points From RA Registries and Pragmatic Trials

Page 2: Practice Points From RA Registries and Pragmatic Trials

Case: A 45-Year-Old Woman With RA of 5 Years’ Duration

Page 3: Practice Points From RA Registries and Pragmatic Trials

Treat-to-TargetA Strategy for RA

Page 4: Practice Points From RA Registries and Pragmatic Trials
Page 5: Practice Points From RA Registries and Pragmatic Trials

MTXMaximize and Maintain

Page 6: Practice Points From RA Registries and Pragmatic Trials

Monotherapy vs Combination Therapy

Page 7: Practice Points From RA Registries and Pragmatic Trials

EULAR Recommendations

Page 8: Practice Points From RA Registries and Pragmatic Trials
Page 9: Practice Points From RA Registries and Pragmatic Trials

Biologic Agents Used in RA

Page 10: Practice Points From RA Registries and Pragmatic Trials
Page 11: Practice Points From RA Registries and Pragmatic Trials

Your Patient Does Not Respond to Treatment With a TNF Inhibitor

Page 12: Practice Points From RA Registries and Pragmatic Trials
Page 13: Practice Points From RA Registries and Pragmatic Trials
Page 14: Practice Points From RA Registries and Pragmatic Trials
Page 15: Practice Points From RA Registries and Pragmatic Trials
Page 16: Practice Points From RA Registries and Pragmatic Trials
Page 17: Practice Points From RA Registries and Pragmatic Trials
Page 18: Practice Points From RA Registries and Pragmatic Trials
Page 19: Practice Points From RA Registries and Pragmatic Trials

Top Related